DK1585483T3 - Doseringsformer af topisk stabiliseret prostaglandin E-forbindelse - Google Patents
Doseringsformer af topisk stabiliseret prostaglandin E-forbindelseInfo
- Publication number
- DK1585483T3 DK1585483T3 DK03800371.1T DK03800371T DK1585483T3 DK 1585483 T3 DK1585483 T3 DK 1585483T3 DK 03800371 T DK03800371 T DK 03800371T DK 1585483 T3 DK1585483 T3 DK 1585483T3
- Authority
- DK
- Denmark
- Prior art keywords
- compound
- topically
- dosage forms
- prostaglandin
- stabilized
- Prior art date
Links
- -1 prostaglandin E compound Chemical class 0.000 title abstract 3
- 239000002552 dosage form Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000004067 bulking agent Substances 0.000 abstract 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical group CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000003961 penetration enhancing agent Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/336,481 US6841574B2 (en) | 2003-01-03 | 2003-01-03 | Topical stabilized prostaglandin E compound dosage forms |
| PCT/US2003/041658 WO2004062632A1 (en) | 2003-01-03 | 2003-12-31 | Topical stabilized prostaglandin e compound dosage forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1585483T3 true DK1585483T3 (da) | 2010-07-19 |
Family
ID=32681022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03800371.1T DK1585483T3 (da) | 2003-01-03 | 2003-12-31 | Doseringsformer af topisk stabiliseret prostaglandin E-forbindelse |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6841574B2 (enExample) |
| EP (1) | EP1585483B1 (enExample) |
| JP (2) | JP2006514068A (enExample) |
| KR (2) | KR101174788B1 (enExample) |
| CN (1) | CN100574763C (enExample) |
| AT (1) | ATE468098T1 (enExample) |
| AU (1) | AU2003300113B2 (enExample) |
| BR (1) | BR0317924A (enExample) |
| CA (1) | CA2512015C (enExample) |
| DE (1) | DE60332656D1 (enExample) |
| DK (1) | DK1585483T3 (enExample) |
| ES (1) | ES2343246T3 (enExample) |
| IL (1) | IL169425A (enExample) |
| PT (1) | PT1585483E (enExample) |
| WO (1) | WO2004062632A1 (enExample) |
| ZA (1) | ZA200505321B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050004226A1 (en) * | 1998-12-10 | 2005-01-06 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
| GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
| US20050181030A1 (en) * | 2003-01-03 | 2005-08-18 | Mo Y. J. | Topical stabilized prostaglandin E compound dosage forms |
| BRPI0408454A (pt) | 2003-03-21 | 2006-04-04 | Nexmed Holdings Inc | composição tópica, método de tratar a ejaculação precoce, e, uso da composição |
| WO2005051960A2 (en) * | 2003-11-22 | 2005-06-09 | Midwest Research Laboratories, Llc | Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents |
| GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
| US20060286172A1 (en) * | 2005-06-03 | 2006-12-21 | Anu Mahashabde | Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same |
| ITMI20051417A1 (it) * | 2005-07-22 | 2007-01-23 | Mipharm S P A | Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina |
| CN101321511A (zh) * | 2005-12-06 | 2008-12-10 | 莫诺索尔克斯有限公司 | 递送活性剂的局部用薄膜组合物 |
| GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
| GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
| US7560489B2 (en) * | 2006-10-11 | 2009-07-14 | Nexmed Holdings, Inc. | Stabilized prostaglandin E composition |
| GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
| ES2921527T3 (es) | 2009-06-03 | 2022-08-29 | Forsight Vision5 Inc | Administración de fármaco en segmento anterior |
| EP2693877A4 (en) | 2011-04-07 | 2014-11-19 | Nexmed Holdings Inc | METHOD AND COMPOSITION FOR TREATING RAYNAUD SYNDROME |
| CN106073986B (zh) | 2011-09-14 | 2019-01-11 | 弗赛特影像5股份有限公司 | 治疗患者的眼睛的装置 |
| PT2911623T (pt) | 2012-10-26 | 2019-11-21 | Forsight Vision5 Inc | Sistema oftálmico para libertação prolongada de fármaco no olho |
| US8900625B2 (en) | 2012-12-15 | 2014-12-02 | Nexmed Holdings, Inc. | Antimicrobial compounds and methods of use |
| US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
| WO2019142015A1 (es) * | 2018-01-18 | 2019-07-25 | Caicedo Pinto, David Felipe | Composicion farmaceutica para la disfuncion erectil de administracion transdermica via uretral en gotas |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3883576A (en) * | 1971-02-02 | 1975-05-13 | Upjohn Co | Prostaglandin E{HD 3 {B analogs |
| US3826823A (en) * | 1972-09-25 | 1974-07-30 | Syntex Inc | Stabilized prostaglandin preparations |
| US3875300A (en) * | 1972-12-18 | 1975-04-01 | Ortho Pharma Corp | Composition for sustained release of a medicament and method of using same |
| US4136162A (en) * | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| US5017382A (en) * | 1979-03-21 | 1991-05-21 | National Research Development Corporation | Controlled release compositions (II) |
| JPS5770816A (en) * | 1980-10-17 | 1982-05-01 | Ono Pharmaceut Co Ltd | Multilayered film preparation of prostagladin of prolonged action |
| JPS58134019A (ja) * | 1982-02-05 | 1983-08-10 | Ono Pharmaceut Co Ltd | プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法 |
| JPS5948409A (ja) * | 1982-09-10 | 1984-03-19 | Teikoku Seiyaku Kk | 矯正的歯牙移動促進剤 |
| JPS6185315A (ja) * | 1984-10-04 | 1986-04-30 | Teikoku Seiyaku Kk | シ−ト状製剤 |
| IE59361B1 (en) * | 1986-01-24 | 1994-02-09 | Akzo Nv | Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension |
| US5219885A (en) * | 1987-02-16 | 1993-06-15 | Froelich Juergen | Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration |
| BR9203277A (pt) * | 1992-08-21 | 1994-03-01 | Cesar Roberto Dias Nahoum | Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao |
| US5380760A (en) * | 1993-11-19 | 1995-01-10 | Minnesota Mining And Manufacturing Company | Transdermal prostaglandin composition |
| SE9501670L (sv) * | 1995-05-05 | 1996-06-10 | Perstorp Ab | Omläggningsset |
| US20020004529A1 (en) * | 1997-10-20 | 2002-01-10 | Gary W. Neal | Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| US6593369B2 (en) * | 1997-10-20 | 2003-07-15 | Vivus, Inc. | Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| US6046244A (en) * | 1997-11-05 | 2000-04-04 | Nexmed Holdings, Inc. | Topical compositions for prostaglandin E1 delivery |
| US6414028B1 (en) * | 1997-11-05 | 2002-07-02 | Nexmed Holdings, Inc. | Topical compositions containing prostaglandin E1 |
| US5942545A (en) * | 1998-06-15 | 1999-08-24 | Macrochem Corporation | Composition and method for treating penile erectile dysfunction |
| WO1999066870A1 (en) * | 1998-06-25 | 1999-12-29 | Lavipharm Laboratories, Inc. | A device and method for the treatment of erectile dysfunction |
| US6323241B1 (en) * | 2000-01-10 | 2001-11-27 | Nexmed (Holdings) Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| KR100402334B1 (ko) * | 2000-06-23 | 2003-10-22 | 환인제약 주식회사 | 알프로스타딜 외용제 |
-
2003
- 2003-01-03 US US10/336,481 patent/US6841574B2/en not_active Expired - Lifetime
- 2003-12-31 WO PCT/US2003/041658 patent/WO2004062632A1/en not_active Ceased
- 2003-12-31 BR BR0317924-9A patent/BR0317924A/pt not_active Application Discontinuation
- 2003-12-31 ES ES03800371T patent/ES2343246T3/es not_active Expired - Lifetime
- 2003-12-31 JP JP2004566647A patent/JP2006514068A/ja active Pending
- 2003-12-31 CA CA2512015A patent/CA2512015C/en not_active Expired - Lifetime
- 2003-12-31 PT PT03800371T patent/PT1585483E/pt unknown
- 2003-12-31 DE DE60332656T patent/DE60332656D1/de not_active Expired - Lifetime
- 2003-12-31 AU AU2003300113A patent/AU2003300113B2/en not_active Expired
- 2003-12-31 KR KR1020117008180A patent/KR101174788B1/ko not_active Expired - Fee Related
- 2003-12-31 CN CN200380110112A patent/CN100574763C/zh not_active Expired - Fee Related
- 2003-12-31 EP EP03800371A patent/EP1585483B1/en not_active Expired - Lifetime
- 2003-12-31 AT AT03800371T patent/ATE468098T1/de active
- 2003-12-31 DK DK03800371.1T patent/DK1585483T3/da active
- 2003-12-31 KR KR1020057012502A patent/KR20050098853A/ko not_active Withdrawn
-
2005
- 2005-06-27 IL IL169425A patent/IL169425A/en unknown
- 2005-06-30 ZA ZA200505321A patent/ZA200505321B/en unknown
-
2011
- 2011-09-14 JP JP2011200752A patent/JP5395138B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR101174788B1 (ko) | 2012-08-20 |
| CN1756532A (zh) | 2006-04-05 |
| CA2512015A1 (en) | 2004-07-29 |
| KR20050098853A (ko) | 2005-10-12 |
| EP1585483A1 (en) | 2005-10-19 |
| AU2003300113B2 (en) | 2010-03-11 |
| IL169425A (en) | 2010-11-30 |
| EP1585483B1 (en) | 2010-05-19 |
| BR0317924A (pt) | 2005-11-29 |
| WO2004062632A1 (en) | 2004-07-29 |
| PT1585483E (pt) | 2010-06-17 |
| US20040131664A1 (en) | 2004-07-08 |
| DE60332656D1 (de) | 2010-07-01 |
| JP2012036196A (ja) | 2012-02-23 |
| CA2512015C (en) | 2011-11-08 |
| ATE468098T1 (de) | 2010-06-15 |
| US6841574B2 (en) | 2005-01-11 |
| CN100574763C (zh) | 2009-12-30 |
| ES2343246T3 (es) | 2010-07-27 |
| JP5395138B2 (ja) | 2014-01-22 |
| EP1585483A4 (en) | 2006-04-19 |
| AU2003300113A1 (en) | 2004-08-10 |
| HK1090293A1 (zh) | 2006-12-22 |
| ZA200505321B (en) | 2006-04-26 |
| KR20110042138A (ko) | 2011-04-22 |
| JP2006514068A (ja) | 2006-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1585483T3 (da) | Doseringsformer af topisk stabiliseret prostaglandin E-forbindelse | |
| RU2370485C2 (ru) | Амидоацетонитрильные производные | |
| BRPI0606318A2 (pt) | composto, composição, e, uso de um composto | |
| EA201000089A1 (ru) | Применение гомо- и сополимеров для стабилизации составов активных ингредиентов | |
| TW200716584A (en) | Dihydrobenzofuran derivatives and uses thereof | |
| BR0116345A (pt) | Composiçõs de contra-ação ao mau cheiro | |
| SV2009003221A (es) | Composiciones de fenilalquilamino carbamato ref. prd2743svpct | |
| BRPI0922364A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
| MX2007005933A (es) | Compuestos de acetamida como fungicidas. | |
| CY1113011T1 (el) | Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην | |
| WO2007062399A3 (en) | Oncogenic ras-specific cytotoxic compound and methods of use thereof | |
| GT200600359A (es) | Fungicidal n-[2-(haloalkoxy)phenyl]heteroarylcarboxamides | |
| EA200970605A1 (ru) | Ингибиторы mapk/erk-киназ | |
| DE60334536D1 (de) | Furylverbindungen | |
| CY1109737T1 (el) | Νεα μεθοδος συνθεσης του (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγομελατινης | |
| ATE477256T1 (de) | Thienylverbindungen | |
| GB2467279A (en) | Tapes comprising barrier coating compositions and components comprising the same | |
| CL2012000374A1 (es) | Metodo para la preparacion de una composicion saborizante activa que comprende una primera reaccion entre un compuesto amino y un carbonilo, resultando una primera mezcla de intermediarios, una segunda reaccion con un segundo compuesto amino solo o en combinacion con un compuesto carbinilo, resultando una segunda mezcla de intermediarios, reacciones serparadas adicionales con compuestos de otras clases quimicas, ultima reaccion que comprende una mezcla de todas las mezclas de intermediarios anteriores. | |
| EA200500074A1 (ru) | Пленочное покрытие для таблеток и каплет | |
| DE602004019083D1 (de) | Sauerstoffbarriereformulierungen | |
| BRPI0704154A (pt) | composição adesiva, método para ligar substratos, e, artigo | |
| IL189883A0 (en) | Isoquinolines as igf-1r inhibitors | |
| DK1885187T3 (da) | Fremgangsmåde til behandling af lægemiddelresistent cancer | |
| TW200517117A (en) | Stabilized compositions containing an oxygen-labile active agent | |
| WO2005097087A3 (en) | Merged ion channel modulating compounds and uses thereof |